Results 31 to 40 of about 3,631,955 (312)

Evaluation of the effectiveness of the proposed therapy on energy metabolism parameters in patients with chronic liver lesions on the background of secondary immunodeficiency state

Медицинский вестник Юга России, 2023
Objective: to study the effect of a combination of azoximer bromide (AB) and human placenta hydrolysate (HPН) on metabolic processes in patients with chronic liver lesions on the background of secondary immunodeficiency.
M. Yu. Perfilyeva, Y. A. Sotskaya
doaj   +1 more source

Secondary immunodeficiency (immunocompromised patient). Lecture

Zdorovʹe Rebenka, 2020
The lecture summarizes modern world data on the determination of secondary immunodeficiency (SID), approaches to diagnosis and treatment. The main immunocompromising factors are listed.
L.I. Chernyshova
doaj   +1 more source

Combination of rheumatoid arthritis and sarcoidosis, which had occurred during rituximab therapy, complicated secondary immunodeficiency and intolerance to the main basic drugs: Case repost and literature review

Научно-практическая ревматология, 2021
Sarcoidosis is a rare multisystem disease which may accompany various autoimmune diseases in 17,6% cases. Despite of the fact that T-cell immunity impairments play a key role in these two conditions, their combination is extremely rare.
O. A. Golovina, N. V. Demidova, A. V. Alekseeva   +2 more
doaj   +1 more source

Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology.

Critical reviews in oncology/hematology, 2022
Secondary immunodeficiency (SID) in patients with B-cell hematological malignancies is a common condition that presents with recurrent infection. SID is due to both the inherent immune defects due to the malignancy, as well as secondary to cancer ...
N. Shah, S. S. Mustafa, D. Vinh
semanticscholar   +1 more source

Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases.

Immunotherapy, 2022
Most primary immunodeficiency diseases, and select secondary immunodeficiency diseases, are treated with immunoglobulin (IG) therapy, administered intravenously or subcutaneously (SCIG).
R. Kobayashi, J. Litzman, S. Rizvi, H. Kreuwel, S. Hoeller, Sudhir Gupta   +5 more
semanticscholar   +1 more source

Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases

Frontiers in Immunology, 2022
Primary immunodeficiencies (PIDs), a heterogenous group of inborn errors of immunity, are predetermined at birth but may evolve with age, leading to a variable clinical and laboratory presentation.
Mark Ballow, Silvia Sánchez-Ramón, Jolan E. Walter, Jolan E. Walter   +3 more
doaj   +1 more source

Immunodeficiency Disorders in Congenital Heart Diseases (Review)

Педиатрическая фармакология, 2023
The study data of the last two decades on primary and secondary immunodeficiency in congenital heart defects (CHD) as a cause of frequent infectious complications before and after cardiac surgery are presented. Based on screenings of various levels, data
Elena A. Degtyareva, Bupe M. Mwela, Andrey P. Prodeus, Dmitry Yu. Ovsyannikov, Marina G. Kantemirova, Olga V. Alekseeva, Dmitry A. Kudlay, Alexey I. Kim, Inessa E. Nefedova, Tatiana V. Rogova, Margarita R. Tumanyan, Ilya A. Korsunskiy   +11 more
doaj   +1 more source

A case of acanthosis nigricans in a HIV-infected patient [PDF]

, 2020
Background: To date, very little information is available concerning the relationship between acanthosis nigricans (AN) and infection with human immunodeficiency virus type 1 (HIV-1).
De Vincentiis, Ludovica, Di Paolo, Marcello, Iacovelli, Alessandra, Mezzaroma, Ivano, Palange, Paolo, Soda, Giuseppe   +5 more
core   +1 more source

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency

Current Oncology, 2022
Secondary antibody deficiency (SAD) is a common complication in chronic lymphocytic leukemia (CLL) which favors the development of life-threatening infections.
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin   +11 more
doaj   +1 more source

Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections.

Immunotherapy, 2022
Aim: Patients with secondary immunodeficiency (SID) are at increased risk of infections and may be treated with immunoglobulin replacement therapy (IgRT). Despite growing efficacy evidence for IgRT in infection prevention in SID, treatment guidelines are
Betsy J Lahue, R. Mallick, Xiang Zhang, Julien Heidt, Yufei Song, A. Koenig, Gabriela Espinoza   +6 more
semanticscholar   +1 more source